N/A N=36 Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty
Local Anesthetic Complication · Local Anesthetic Drug Adverse Reaction
Primary: Number of Participants With Edema — 12 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=109 Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Diabetes Mellitus, Type 2 · Noninsulin-Dependent Diabetes Mellitus
Primary: Change From Baseline at 24 Weeks in Hemoglobin A1c (HbA1c), DMR vs Sham. — -0.60; -0.30; -1.85; -1.60 percentage change from baseline
Phase 2 N=120 SGI-110 in Combination With Carboplatin in Ovarian Cancer
Ovarian Cancer
Primary: Stage 1: Dose Limiting Toxicities — 0; 4 Participants
Phase 3 N=46 Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Primary Hyperparathyroidism · Parathyroid Adenoma · Parathyroid Hyperplasia
Primary: Change in Lumbar Spine Bone Mineral Density — 0.030; 0.042; -0.016 g/cm^2 — p=< 0.00001
N/A N=2,452 Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19
Depression
Primary: Change in Adolescent Depressive Symptom Severity — 14.31; 14.15; 14.22; 12.57 Score on a scale
Early Phase 1 N=26 The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome
Headache · Post-Concussion Syndrome
Primary: Immediate Change in Headache Scores With a Visual Analog Scale (VAS) — 5.6; NA; 3.5; NA units on a scale
N/A N=24 Longevity of Multi-Slitted Catheter With Lantern Technology
Insulin Dependent Diabetes Mellitus 1
Primary: Time to Infusion Set Failure — 8.0 days
N/A N=19 mHealth for Patient Self-Management of Opioid Use Disorder
Opioid-use Disorder
Primary: Usability Score — 89.5 score on a scale
N/A N=55 Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism
Cataract
Primary: Uncorrected Distance Visual Acuity (UCDVA) of 20/20 or Better — 45 Eyes
Phase 2 N=22 Sequential Therapy for the Treatment of Severe Bipolar Depression.
Bipolar Depression · Suicidal Ideas · Suicidal Ideation
Primary: BDM Score (BISS-derived MADRS) Change From Baseline at Day 42 — 3.3; 2.4; -1.06; 0 score on a scale — p=.03
N/A N=20 Intracochlear Potentials: Volta Study
Hearing Loss
Primary: Normative Voltage Tomography Data — 19; 1; 19; 1 Participants
Phase 2 N=82 Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
Actinic Keratosis
Primary: Part 1: To Identify the Maximum Tolerated Dose (MTD) Levels After Once Daily Treatment for 2 or 3 Days — 0; 0; 0; 1 Participants
N/A N=87 Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
Parkinson Disease · Parkinsonian Disorders
Primary: Demonstrate the Presence of Alpha-Synuclein Inclusions in the Skin of Parkinson's Disease and Compare With an Atypical Parkinsonism Group and With a Healthy Control…
N/A N=109 Trial of Simulation-based Mastery Learning to Communicate Diagnostic Uncertainty
Uncertainty · Communication Research · Emergency Medicine
Primary: % of Residents Who Pass the UCC at the T2 Assessment — 29; 2 Participants
Phase 3 N=102 Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
Heart Transplant Recipients
Primary: Peak Oxygen Consumption — 23.9; 22.0 ml/kg/min